Numerous xenobiotics regulate cellular functions by altering transcription of target genes. Use of sensitive and specific biomarkers based on gene transcript levels may help clarify the shape of the dose-response curve in the low-dose region associated with human exposures to environmental concentrations of chemicals. We have quantified gene transcription induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in both animal models and humans with the use of Northern analysis and PCR-based methods. In addition, we describe a rapid and sensitive in vitro assay that we have used to screen chemicals and biological samples for their ability to alter gene transcription. Whereas some of the endpoints in our studies such as cytochrome P-450 1A1 are predictive indicators of exposure and dose, other gene responses such as growth factors are more complex and represent a critical event, progression, or adaptation to a pathological alteration. In conclusion, measurement of toxicant-induced gene transcription will contribute to the usefulness of biomarkers in addressing issues of human health and environmentally induced disease.
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Toxicology research can be applied in both a predictive and preventative manner to evaluate potential human health risksresultingfrom exposures to chemicals and other factors in the environment.
Within this framework, the uses of biomarkers range from an early identification of exposure to a prognosticindicationof disease progression. Provided sufficient mechanistic data exist regarding the pathway by which a xenobiotic induces an adverse effect, information on biomarkers may be used to better predict the dose-response for the outcome of concern, or, alternatively, the biomarker information may be used to justify intervention, exposure control, or preventative therapy.
In either case, we can improve the application of biomarkers by considering the nature of the relation between exposure, target tissue concentration, and early cellular response, and by determining the molecular events that mediate the early or later responses to cellular, tissue,and organ disease. 
TCDD Regulation of Epidermal Growth

Factor Receptor
The epidermal growth factor receptor (EGFR) is a transmembrane glycoproteinwith a ligand-dependent intrinsic tyrosine kinase activity (for reviews see 22-24). The receptor plays a key rolein the regulationof cell growth and differentiation.
After In a single-dose study with rats, RT-PCR was used for quantitative examination and biological modeling of the dose-response curve for CYPIA1 induction (Fig.2) . In this study TCDD was administered from 0.1 to 10 000 ng/kg body weight.
Quantification of
Other dioxin-responsive genes that were quantified included plasminogen activator inhibitor 2, transforming growth factor-a, and UDP-glucuronosyltransferase-1 (UGT1 This type of data can be used to reduce and refine the reliance on in vivo studies as well as to identify endpoints that may be used in biomarker studies, both in animals and in humans.
With limited mechanistic data it is feasible to better design animal studies with the objectives of obtaining information on critical molecular events that are important in understanding species differences as well as high-to lowdose extrapolations.
An example of a profile generated by using this system with 3-methylcholanthrene, an Ah receptor agonist, in shown in Fig. 3 .
In summary, these examples illustrate ongoing research in our laboratory focused on characterizing the regulationof dioxin-responsivegenes. These endpoints are being quantified in dioxin-exposed human populations to determine the validity for use as exposure, effect, and susceptibility biomarkers.
A current limitation is the incomplete knowledge regarding the critical genes regulated by dioxin that result in the manifestation of toxicity and disease.
However 
